Prescriptions for health and happiness
May 2, 2022
In addition to all the fear and chaos it has wreaked, COVID-19 has changed the way we think about our health. Thanks to the psychological, and even the physical, impacts of protracted quarantines and...
Statins should be continued in hospitalized patients with COVID-19
May 2, 2022
Clinical question: Does discontinuation of atorvastatin in those hospitalized with COVID-19 change the risk of mortality and ventilation? Dr. Clark Background: Statins are ubiquitous. Statins...
Post-op remote monitoring may help catch drug errors, ease pain
October 5, 2021
"Virtual care with RAM technologies that measured heart rate, blood pressure, temperature, oxygen saturation, and body weight allowed for a large absolute difference in identifying the drug errors."
Akathisia: “Ants in the Pants”
February 22, 2021
If left unresolved, akathisia can torment patients to sheer exhaustion.
Predicting patient risk of medication-related harm
November 18, 2020
Clinicians can calculate the risk of a patient suffering medication-related harm post-discharge.
September 12, 2019
In The Literature's Short Takes
Standardized communication may prevent anticoagulant adverse drug events
September 2, 2019
What information is needed on discharge to reduce anticoagulant adverse drug events (ADEs)?
Older adults’ interested in conversations about deprescribing
July 29, 2019
Among older adults, what attitudes exist toward deprescribing?
Reducing adverse drug reactions
June 12, 2019
Both in and out of the hospital, adverse drug reactions remain a problem.
Multifaceted pharmacist intervention may reduce postdischarge ED visits and readmissions
August 2, 2018
Can a multifaceted intervention by a clinical pharmacist reduce the rate of ED visits and readmission over the subsequent 180 days?